In this digital transformation race sprung about by COVID-19, companies like IMAPAC have rapidly increased the use of digital tools to stay afloat during the pandemic. Revamping from having a portfolio that consisted… read more

INFOGRAPHIC OF THE WEEK In a recent market outlook analysis by Genetic Engineering & Biotechnology News, the APAC global cell and gene therapy space has been predicted to emerge as a major market.… read more

IMAPAC recently rounded up its “Corona360 In-Conversation” series of live moderated interviews. It brought together vaccine industry experts in lively, thought-provoking discussions on the challenges and possible solutions in the race to develop… read more

WHO Lists Additional COVID-19 Vaccine for Emergency Use and Issues Interim Policy Recommendation The Sinopharm COVID-19 vaccine, produced by Beijing Bio-Institute of Biological Products Co Ltd, has been listed for global emergency use.… read more

WHO Welcomes Sweden’s Announcement to Share COVID-19 Vaccine Doses with COVAX Sweden has announced a donation of 1 million doses of the AstraZeneca vaccine to COVAX in order to support supplies in low-income… read more

ViiV Healthcare Initiates Rolling Submission of New Drug Application with US FDA for Long-Acting Cabotegravir for Prevention of HIV Global specialist HIV company ViiV Healthcare has begun a rolling submission of a new… read more

BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore The setting up of its regional headquarters in Singapore is part of BioNTech’s global expansion strategy, and… read more

All Californians 16+ Now Eligible for COVID-19 Vaccines Following major milestones in its vaccination program, with almost half its population aged 16 and up and 73.9% of seniors over 65 have received one… read more

All Californians 16+ Now Eligible for COVID-19 Vaccines Following major milestones in its vaccination program, with almost half its population aged 16 and up and 73.9% of seniors over 65 have received one… read more

Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine A rare and critical type of blood clot called cerebral venous sinus thrombosis (CVST) has been detected in combination with low levels… read more

Bharat Biotech and ICMR Announce Interim Results from Phase 3 trials of COVAXIN®; Demonstrates overall Interim Clinical Efficacy of 78% and 100% efficacy against Severe COVID-19 disease Globally recognized biotechnology innovator and distributor,… read more

Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine Program Ahead of 2nd Annual Vaccines Day Moderna, Inc., the biotechnology company spearheading mRNA therapeutics and vaccines that have delivered an estimated 132 million… read more

Fareva to grow its newly acquired biomanufacturing capabilities A leading third-party manufacturer in the small molecule active pharmaceutical ingredient (API) and finished formulation industry, Fareva entered the biologics CDMO sector last year, subsequently… read more